Company intelligence / Profile preview

Rysk

Cambridge, Massachusetts, United States
Ownership
Private
Development stage
Other
01

Overview

Rysk (rysk.bio) is a biotechnology and biosecurity company focused on safeguarding the synthetic biology ecosystem through advanced DNA synthesis screening. The company develops technology to screen DNA orders for potential biological threats, such as pathogens and toxins, ensuring that synthetic genetic material is used for legitimate research and development. By providing automated sequence and customer screening solutions, Rysk helps DNA synthesis providers comply with international biosecurity standards and government regulations. Its platform acts as a critical chokepoint to prevent the accidental or intentional creation of dangerous biological agents while supporting the continued innovation of the life sciences industry.

Industry
Non-Drug Biotech
02

Partnerships

International Gene Synthesis Consortium (IGSC)

Beyond the preview

Go deeper on Rysk.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rysk.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call